Pneumococcal infections, caused by the bacterium Streptococcus pneumoniae, remain a significant global public health concern. This Gram-positive bacterium is a leading cause of respiratory tract infections, including pneumonia, otitis media, and sinusitis. Pneumococcal infections can also lead to invasive diseases such as bacteremia and meningitis, particularly in vulnerable populations such as young children, the elderly, and individuals with weakened immune systems. Transmission of S. pneumoniae occurs through respiratory droplets, and colonization in the nasopharynx is common, especially in children. The bacterium possesses various virulence factors, including a polysaccharide capsule that aids in evading the host immune system. When infection occurs, the clinical presentation can vary widely, ranging from mild upper respiratory symptoms to severe pneumonia or life-threatening invasive diseases. Preventive measures for pneumococcal infections include vaccination, with pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPVs) targeting different age groups. Vaccination has led to a significant reduction in the incidence of pneumococcal diseases, highlighting the importance of immunization in public health efforts.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain